{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:32:22Z","timestamp":1792783942897,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001425","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["IG11647"],"award-info":[{"award-number":["IG11647"]}],"id":[{"id":"10.13039\/501100001425","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Italian Ministry for the University and Research","award":["PRIN 2010"],"award-info":[{"award-number":["PRIN 2010"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.critrevonc.2015.02.004","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T19:50:36Z","timestamp":1424202636000},"page":"1-11","source":"Crossref","is-referenced-by-count":176,"title":["Erdheim\u2013Chester disease: A systematic review"],"prefix":"10.1016","volume":"95","author":[{"given":"Mauro","family":"Cives","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Maria","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Dicuonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marirosa","family":"Cristallo Lacalamita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ingravallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Silvestris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Dammacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2015.02.004_bib0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/BOR.0b013e32834d861d","article-title":"Erdheim\u2013Chester disease","volume":"24","author":"Haroche","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.critrevonc.2015.02.004_bib0220","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11926-014-0412-0","article-title":"Erdheim\u2013Chester disease","volume":"16","author":"Haroche","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.critrevonc.2015.02.004_bib0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1750-1172-8-137","article-title":"Erdheim\u2013Chester disease: a comprehensive review of the literature","volume":"8","author":"Mazor","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"10.1016\/j.critrevonc.2015.02.004_bib0230","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/annrheumdis-2012-202542","article-title":"The multifaceted clinical presentations and manifestations of Erdheim\u2013Chester disease: comprehensive review of the literature and of 10 new cases","volume":"72","author":"Cavalli","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.critrevonc.2015.02.004_bib0235","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim\u2013Chester disease","volume":"124","author":"Diamond","year":"2014","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.critrevonc.2015.02.004_bib0240","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim\u2013Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2015.02.004_bib0245","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1634\/theoncologist.2013-0341","article-title":"New insights into the molecular pathogenesis of Langerhans cell histiocytosis","volume":"19","author":"Rizzo","year":"2014","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.critrevonc.2015.02.004_bib0250","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.mayocp.2014.01.023","article-title":"Erdheim\u2013Chester Disease: characteristics and management","volume":"89","author":"Munoz","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.critrevonc.2015.02.004_bib0255","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","article-title":"Dramatic efficacy of Vemurafenib in both multisystemic and refractory Erdheim\u2013Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation","volume":"121","author":"Haroche","year":"2013","journal-title":"Blood"},{"issue":"28","key":"10.1016\/j.critrevonc.2015.02.004_bib0260","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1200\/JCO.2012.41.9911","article-title":"Tumor necrosis factor \u03b1 as a master regulator of inflammation in Erdheim\u2013Chester disease: rationale for treatment of patients with infliximab","volume":"30","author":"Dagna","year":"2012","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.critrevonc.2015.02.004_bib0265","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1182\/blood-2010-04-279240","article-title":"Rationale and efficacy of interleukin-1 targeting in Erdheim\u2013Chester disease","volume":"116","author":"Aouba","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.critrevonc.2015.02.004_bib0270","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/blood-2010-06-294108","article-title":"CNS involvement and treatment with interferon-\u03b1 are independent prognostic factors in Erdheim\u2013Chester disease: a multicenter survival analysis of 53 patients","volume":"117","author":"Arnaud","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.critrevonc.2015.02.004_bib0275","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00415-006-0160-9","article-title":"Neurological manifestations and neuroradiological presentation of Erdheim\u2013Chester disease: report of 6 cases and systemic review of the literature","volume":"253","author":"Lachenal","year":"2006","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.critrevonc.2015.02.004_bib0280","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/acr.22100","article-title":"A 72-year-old man with dyspnea, circumferential aortic thickening, and weight loss","volume":"65","author":"Los Arcos-Bertiz","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.critrevonc.2015.02.004_bib0285","article-title":"Neurological manifestations in Erdheim\u2013Chester disease: two case reports","author":"Rouco","year":"2014","journal-title":"Neurologia"},{"issue":"4","key":"10.1016\/j.critrevonc.2015.02.004_bib0290","first-page":"669","article-title":"BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim\u2013Chester disease","volume":"211","author":"Cangi","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.critrevonc.2015.02.004_bib0295","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups","volume":"211","author":"Berres","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.critrevonc.2015.02.004_bib0300","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/1097-0142(197811)42:5<2187::AID-CNCR2820420516>3.0.CO;2-Q","article-title":"Preventive central nervous system irradiation in children with acute nonlymphocytic leukemia","volume":"42","author":"Dahl","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2015.02.004_bib0305","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2141.1984.tb06102.x","article-title":"CNS involvement in acute myelomonoblastic leukemia","volume":"58","author":"Stavem","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2015.02.004_bib0310","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/blood.V84.2.355.355","article-title":"Prevention and treatment of meningeal leukemia in children","volume":"84","author":"Pinkel","year":"1994","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2015.02.004_bib0315","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/pbc.22955","article-title":"CNS irradiation in pediatric acute myeloid leukemia: equal results by 12 or 18Gy in studies AML-BFM98 and 2004","volume":"57","author":"Creutzig","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2015.02.004_bib0320","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijrobp.2010.01.062","article-title":"Impact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement","volume":"80","author":"Mayadev","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.critrevonc.2015.02.004_bib0325","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3174\/ajnr.A2707","article-title":"Erdheim\u2013Chester disease of the central nervous system: new manifestations of a rare disease","volume":"32","author":"Sedrak","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1016\/j.critrevonc.2015.02.004_bib0330","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/EP:15:2:159","article-title":"Pituitary pathology in Erdheim\u2013Chester disease","volume":"15","author":"Kovacs","year":"2004","journal-title":"Endocr Pathol"},{"issue":"5","key":"10.1016\/j.critrevonc.2015.02.004_bib0335","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.beem.2009.05.009","article-title":"Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary","volume":"23","author":"Carpinteri","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.critrevonc.2015.02.004_bib0340","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12020-014-0184-3","article-title":"Surgical biopsies in patients with central diabetes insipidus and thickened pituitary stalks","volume":"47","author":"Jian","year":"2014","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/j.critrevonc.2015.02.004_bib0345","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1002\/art.24848","article-title":"18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim\u2013Chester disease","volume":"60","author":"Arnaud","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.critrevonc.2015.02.004_bib0350","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1148\/radiol.10090320","article-title":"Cerebral, facial and orbital involvement in Erdheim\u2013Chester disease: CT and MRI findings","volume":"255","author":"Drier","year":"2010","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.critrevonc.2015.02.004_bib0355","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4065\/mcp.2010.0663","article-title":"Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes","volume":"86","author":"Kermani","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.critrevonc.2015.02.004_bib0360","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.md.0000145368.17934.91","article-title":"Cardiovascular involvement, an overlooked feature of Erdheim\u2013Chester disease: report of 6 new cases and a literature review","volume":"83","author":"Haroche","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"25","key":"10.1016\/j.critrevonc.2015.02.004_bib0365","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1161\/CIRCULATIONAHA.108.825075","article-title":"Images in cardiovascular medicine. Cardiac involvement in Erdheim\u2013Chester disease: magnetic resonance and computed tomographic scan imaging in a monocentric series of 37 patients","volume":"119","author":"Haroche","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.critrevonc.2015.02.004_bib0370","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.semarthrit.2011.11.004","article-title":"Treatment of Erdheim\u2013Chester disease with long-term high-dose interferon-\u03b1","volume":"41","author":"Hervier","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.critrevonc.2015.02.004_bib0375","doi-asserted-by":"crossref","first-page":"13748","DOI":"10.3390\/ijms140713748","article-title":"KRAS and MAPK1 gene amplification in Type II ovarian carcinomas","volume":"14","author":"Rahman","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.critrevonc.2015.02.004_bib0380","first-page":"285","article-title":"BRAF and MEK gene rearrangements in melanoma: implications for targeted therapy","volume":"18","author":"Madureira","year":"2014","journal-title":"Mol Diagn Ther"},{"issue":"8","key":"10.1016\/j.critrevonc.2015.02.004_bib0385","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1158\/2159-8290.CD-13-0014","article-title":"Targeting the BRAF V600E mutation in multiple myeloma","volume":"3","author":"Andrulis","year":"2013","journal-title":"Cancer Discov"},{"issue":"7051","key":"10.1016\/j.critrevonc.2015.02.004_bib0390","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi","volume":"436","author":"Michaloglou","year":"2005","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.critrevonc.2015.02.004_bib0395","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/modpathol.2011.43","article-title":"Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps\/adenomas indicates a senescence barrier in the serrated route to colon cancer","volume":"24","author":"Kriegl","year":"2011","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.critrevonc.2015.02.004_bib0400","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ncb2784","article-title":"A complex secretory program orchestrated by the inflammasome controls paracrine senescence","volume":"15","author":"Acosta","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"6","key":"10.1016\/j.critrevonc.2015.02.004_bib0405","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1182\/blood-2013-02-482984","article-title":"Detection of an NRAS mutation in Erdheim\u2013Chester disease","volume":"122","author":"Diamond","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2015.02.004_bib0410","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/his.12443","article-title":"An NRAS mutation in a case of Erdheim Chester disease","volume":"66","author":"Aitken","year":"2015","journal-title":"Histopathology"},{"issue":"19","key":"10.1016\/j.critrevonc.2015.02.004_bib0415","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2014-04-570937","article-title":"Recurrent RAS and PIK3CA mutations in Erdheim\u2013Chester disease","volume":"124","author":"Emile","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.critrevonc.2015.02.004_bib0420","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.18632\/oncotarget.1964","article-title":"BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim\u2013Chester disease","volume":"5","author":"Janku","year":"2014","journal-title":"Oncotarget"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842815000281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842815000281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T23:02:09Z","timestamp":1598742129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842815000281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1040842815000281"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2015.02.004","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}